版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
(pitchBooK
EMERGINGTECHRESEARCH
IPOPipeline:IdentifyingPotentialVC-BackedIPOCandidatesin2024
PitchBookData,Inc.
JohnGabbertFounder,CEO
NizarTarhuniVicePresident,Institutional
ResearchandEditorial
PaulCondraHeadofEmerging
TechnologyResearch
InstitutionalResearchGroup
Analysis
PitchBookisaMorningstarcompanyprovidingthemostcomprehensive,most
accurate,andhard-to-finddataforprofessionalsdoingbusinessintheprivatemarkets.
TheEmergingTechResearchTeam
EricBellomo,BrendanBurke,AaronDeGagne,
AlexFrederick,JonathanGeurkink,KaziY.Helal,
DerekHernandez,AliJavaheri,RobertLe,
JohnMacDonagh,RebeccaSpringer,
JamesUlan,RudyYang
Introduction
pbinstitutionalresearch@
Asthestockmarketreachesnewpeaks,discussionofapossiblerevivalofthe
Publishing
DesignedbyCarolineSuttie
PublishedonMarch4,2024
Contents
Introduction
1
IPOperformancecharts
2
Selectcompanyhighlights
4
AsteraLabs
4
Circle
5
Databricks
6
Datavant
7
EpicGames
8
FBN
9
Generate:Biomedicines
10
Getir
11
HeartFlow
12
Klarna
13
Noom
14
Northvolt
15
RivusPharma
16
Rokt
17
Rubrik
18
SierraSpace
19
Stripe
20
Turo
21
Zipline
22
Zocdoc
23
IPOmarkethastakencenterstage.However,recentgrowthinthestockmarkethaslargelybeenpropelledbytechnologystalwartswithstrongoperating
fundamentalsasopposedtospeculativeventure-backedstartupswithunproventrackrecords.PitchBook’sproprietaryindexandvaluationdatashowshowtechstartupperformancehasdramaticallyunderperformedthebroaderstockmarket(seechartsbelow),raisingquestionsastohowmuchinvestorenthusiasmexistsforspeculativeIPOs.ThesparseIPOactivitythathasoccurredoverthepasttwoyearshasmainlyconsistedoflargercompaniesthathavebeensupportedby
largecorporateinvestorparticipation—verydifferentfromVC-backedstartups.
Anotherfactorthatisdifferentthiscycleisthepresenceofadeeperprivatemarketlandscapethatprovidesalternateroutestocapital,suchassecondariesofferings,thatmayreducetheneedforpublicliquidity.Still,withpublicmarketmultiples
holdingsteadyathealthylevelsandalong-termIPOdroughtleavingdealmakerschompingatthebit,it’slikelysomeVC-backedcompanieswilltestthepublic
watersin2024.
WepolledourEmergingTechnologyResearchteamtogettheirviewsonthemostlikelyVC-backedIPOcandidatesoverthenextyearassumingmarketsmaintain
currentlevels.Whilecountlessexternalandinternalfactorsultimatelydeterminewhetheracompanyseekstogopublic,ouranalystssoughttoidentifyventure-
backedstartupswithcompellingIPOcharacteristicssuchasstrongrevenuegrowthandmarginpotential,durablebusinessesmodels,capablemanagementteamswithsuccessfultrackrecords,and/orproductandtechnologyofferingswithrealistic
chancesofdisruptionandgrowth.Weidentify20possibleIPOcandidatesbelow.
1
$1,421.7
PitchBookAnalystNote:IPOPipeline:IdentifyingPotentialVC-backedIPOCandidatesin2024
PaulCondra
HeadofEmergingTechnology
Research
paul.condra@
IPOperformancecharts
VC-backedIPOshaveunderperformedbroadermarkets
VC-backedpublicmarketreturnsrebasedto100
460
410
360
310
260
210
160
110
60
Jan2019Jul2019Jan2020Jul2020
Nasdaq100
Jan2021Jul2021Jan2022Jul2022Jan2023Jul2023Jan2024
S&P500VC-BackedIPOIndex
Source:PitchBook•Geography:Global•*AsofFebruary29,2024
VC-backedstartupshavenotheldvalueaspubliccompanies
AggregatechangeinvaluationfromIPOforVC-backedIPOs
$1,500$1,400$1,300$1,200$1,100
$1,000
$1,444.9
Aggregatepostvaluation($B)
AtIPOOnFebruary29,2024
Source:PitchBook•Geography:Global
2
PitchBookAnalystNote:IPOPipeline:IdentifyingPotentialVC-backedIPOCandidatesin2024
2024IPOpipelineforVC-backedstartups*
Company
Founded
Vertical
Valuation
Lastraised
Totalraised
IPOprobability**
M&Aprobability
AsteraLabs
2017
AI&ML
$3.2billion
$150.0million
SeriesD,
April21,2021
$235.0million
44%
53%
Circle
2023
Crypto
$7.7billion(2022)
403.0million,
April11,2022
$1.1billion
75%
23%
Databricks
2013
Datasoftware&
Systems
$43.2billion
(2023)
N/A
$4.2billion
91%
7%
Datavant
2017
HealthcareIT
$7.0billion(2021)
Undisclosed,
October3,2023
$83.0million
disclosed
70%
16%
EpicGames
1991
Gaming
$30.0billion
$2.0billion,
April11,2022
$6.1billion
94%
1%
FBN
2014
Agtech
$3.8billion
$154.9million,
October13,2023
$939.3million
79%
19%
Generate:
Biomedicines
2018
Biopharma
$2.0billion
$273.0million,
September6,2023
$673.0million
95%
2%
Getir
2015
Foodtech
$2.5billion
$500.0million,
September8,2023
$2.3billion
91%
7%
HeartFlow
2010
Medtech(medicalimaging)
$1.6billion,
June13,2019
$215.0million,
March2,2023
$828.8million
94%
4%
Klarna
2005
Fintech
$6.7billion
Undisclosed,
January1,2024
$4.7billion
92%
6%
Noom
2008
Digitalhealth
$3.7billion,
May25,2021
$540million,
May25,2021
$668.8million
80%
18%
Northvolt
2016
Climatetech
$11.8billion
(2021)
$145.3million,
November21,2023
$14.3billion
97%
1%
RivusPharma
2019
Biopharma
$432.0million
$132.0million,
August19,2022
$167.0million
93%
4%
Rokt
2012
E-commerce
$2.0billion
Undisclosed,
November30,2022
$486.6million
69%
29%
Rubrik
2014
Cybersecurity
$4.0billion
$108.2milliondebtfinancing,
August17,2023
$1.2billion
88%
10%
SierraSpace
2021
Spacetech
$5.3billion
$290.0million,
September26,2023
$1.7billion
86%
12%
Stripe
2009
Fintech
$50.0billion
$6.9billion,
March15,2023
$9.1billion
96%
2%
Turo
2009
Mobility
$1.3billion
$67.5million,
September22,2023
$527.6million
88%
10%
Zipline
2014
Supplychain
$4.2billion
$330.4million,
April11,2023
$884.3million
97%
1%
Zocdoc
2007
HealthcareIT
$1.6billion(2015)
Undisclosed,
January1,2022
$504.0milliondisclosed
97%
1%
Source:PitchBook•Geography:Global•*AsofDecember31,2023
**Note:Probabilitydataisbasedon
PitchBookVCExitPredictormethodology
.
3
(pitchBooK
PitchBookAnalystNote:IPOPipeline:IdentifyingPotentialVC-backedIPOCandidatesin2024
Selectcompanyhighlights
BrendanBurke
SeniorAnalyst,Emerging
Technology
brendan.burke@
Vertical:AI&ML
Founded:2017
Founders:CEO/Co-founderJitendraMohan,President/Co-founderSanjayGajendra,ChiefProductOfficer/Co-founderCaseyMorrison
Lastraised:$150.0million,October4,2023
Totalraised:$235.0million
Post-moneyvaluation:$3.2billion,
May17,2022
Notableinvestors:FidelityManagement&Research,IntelCapital,SutterHillVentures,VentureTechAlliance,GlobalLink1Capital
Revenue:$115.8millionFY2023
Profitablein2023
Publiccompetitors:AMD,CadenceDesignSystems,Nvidia,Samsung,Synopsys
Privatecompetitors:MemVerge,XConnTechnologies
VCExitPredictor
.IPO:44%probability.M&A:53%probability.Noexit:3%probability
Note:Probabilitydataisbasedon
PitchBookVCExitPredictorMethodology.
AsteraLabs
Companyoverview
AsteraLabsspecializesinadvancedconnectivitysemiconductorsfordatacenters.Thecompany’sproductsprimarilyfocusonenhancingtheperformanceand
reliabilityofhigh-speeddatatransferincloud,enterprise,andhigh-performance
computingenvironments.AsteraLabsoffersarangeofPCIe(peripheral
componentinterconnectexpress)solutions,includingthemostwidelydeployedretimersforclouddatacenters—electroniccomponentsusedinhigh-speeddatacommunicationsystemstoimprovesignalintegrityandlatency.Theseproductsenablecustomerstoachievehigherdatarates,lowerpowerconsumption,and
improvedsystemscalability.TheyhavebecomeincreasinglyimportanttomanagethehighthroughputofAIsystemsincustomizeddatacenters.
ThecompanypartnerswithIntel,inpartduetoitscorporateVCrelationship,to
integrateitscomponentswithIntelcloudservers.IntelCapitaloffersanEmbeddedExpertprogramtouseIntel’sstafftoco-developstartupproductsandintegrate
themwithIntelhardware.AsteraLabshastakenadvantageofthisasanearly
integrationpartnerwithIntel’snewgeneration5Xeonprocessors.Forthisreason,thecompanymaybeunderexposedtoNvidia’sgrowth,1whilestillabletosupportIntel’s$15billiondatacenterbusiness.
IPOrationale
•AIsemiconductorcompanieshaveoutperformedthemarketintermsofrevenuemultipleappreciation.ThemedianAIsemiconductorstockinourcompsetgrew71%in2023and23%inQ42023—bothtopsamongallAIsegments,includingcoresoftwareandapplications.
•AsteraLabsmeetssomeofthecriteriaforlistingsinthecurrentmarket
environmentwithapublic-readyboardand44.9%revenuegrowthin2023.Thecompanyisnotprofitableanddoesnotmeetthe“ruleof40,”soitmayrelyonmomentumfromAIsemiconductorspendingforavaluationpremium.
•Thecompanybenefitsfromtailwindsinfit-outsofspecialtyAIdatacenters.
SpendingongenerativeAIhardware,includingcompute,storage,and
networking,grewto$7.2billionin2023.Growthisexpectedtoremainhighin2024.Thismarketopportunityacceleratesthegrowthofthecompany’sstated$17.2billionaddressablemarketfromenterprisenetworkingsemiconductors.
1:“AIDataCenterStartupAsteraLabsPlansMarchIPO,”TheInformation,CoryWeinbergandAnissaGardizy,February1,2024
4
(pitchBooK
PitchBookAnalystNote:IPOPipeline:IdentifyingPotentialVC-backedIPOCandidatesin2024
RobertLe
SeniorAnalyst,Emerging
Technology
robert.le@
Vertical:Crypto/blockchain
Founded:2013
Founder:JeremyAllaire
Lastraised:$403.0,April2022
Totalraised:$1.1billion(CoinbaseandCircledissolvedtheirconsortiumgoverningUSDCinAugust2023,withCoinbasetakinganequitystakeinCircle.)
Post-moneyvaluation:$7.7billion,
April11,2022
Notableinvestors:BlackRock,Fidelity,Sequoia,GoldmanSachs,Accel,GeneralCatalyst,Pantera
Revenue:$1.5billionin2023(PitchBookestimate),$1.8-2.2billionin2024
(PitchBookestimate)
Publiccompetitors:WesternUnion,
Wise,Remitly
Privatecompetitor:Paxos
VCExitPredictor
.IPO:75%probability.M&A:23%probability.Noexit:2%probability
Note:Probabilitydataisbasedon
PitchBookVCExitPredictorMethodology.
Circle
Companyoverview
CircleisthedeveloperandissuerofUSDCoin(USDC),adigitalcurrencypegged
totheUSdollartomaintainastablevalue.Thecompanyoffersinfrastructurefor
theimplementationofthisstablecoininvariousfinancialtransactionsanddigital
applications.Circle’saimistofacilitateseamlessandefficientdigitalpaymentsandfinancialservices,leveragingthetechnologytobridgetraditionalfiatcurrencies
withthedigitaleconomy.Itsroleinthecryptoecosysteminvolvesregulatory
compliance—ensuringthatUSDCremainstransparentandstableasamediumofexchangeandstoreofvalue.
IPOrationale
•CirclefiledaconfidentialdraftS-1inJanuary2024.Thecompanypreviously
announcedaSPACmergertogopublicin2021,adealthatwasultimately
canceledinlate2022amidthecryptofallout.Duringthattime,thecompany
reportedQ32022revenuesof$274.0millionandanetincomeof$43.0million.ThevaluationCirclewasseekingatthetimewas$9.0billion.
•Thecompanycontinuestoexperiencestronggrowthandwasalsoestimatedtobeprofitablein2023,whichisararityforpublictechofferings.Webelieveagoodgrowthstoryplusprofitabilitywillgarnersignificantinvestorinterest.Thecaveatisthattechvaluationmultiplesoverallinthepublicmarketshavedeclined,sothevaluationCirclewillfetchwon’tbecommensuratewith
itsgrowth.
•Coinbase,theclosestpeercomp,hasbeentradingat8-10xforwardrevenue,whichimpliesCirclecouldgarnera$14.4-22.0billionvaluationinthe
publicmarket.
5
(pitchBooK
PitchBookAnalystNote:IPOPipeline:IdentifyingPotentialVC-backedIPOCandidatesin2024
DerekHernandez
SeniorAnalyst,Emerging
Technology
derek.hernandez@
Vertical:InfrastructureSaaS(datasoftware&systems)
Founded:2013
Founders:ArsalanTavakoli,IonStoica,AndyKonwinski,ReynoldXin,PatrickWendell,AliGhodsi,MateiZaharia
Lastraised:$500.0million,
September14,2023
Totalraised:$4.18billion
Post-moneyvaluation:$43.2billion,November10,2023
Notableinvestors:ARKVentureFund,
CapitalOneVentures,Nvidia,T.RowePrice,CounterpointGlobal,FranklinTempleton,AndreessenHorowitz,Microsoft
Revenue:Crossed$1.5Brevenuerunrateatmorethan50%revenueYoYgrowthandnon-GAAPsubscriptiongrossmarginsof85%(Q22023)
Publiccompetitors:Snowflake,AmazonWebServices,MicrosoftAzure,GoogleCloud
Privatecompetitors:
CockroachLabs,MotherDuck,Redis
VCExitPredictor
.IPO:91%probability
.M&A:7%probability.Noexit:2%probability
Note:Probabilitydataisbasedon
PitchBookVCExitPredictorMethodology.
Databricks
Companyoverview
Databricksisaunifiedanalyticsplatformdesignedtohelporganizationsharness
thepowerofbigdataandmachinelearning.Itwasfoundedbythecreatorsof
ApacheSpark,awidelyusedopen-sourceclustercomputingframeworkforbigdataprocessing.Databricksprovidesacollaborativeenvironmentfordatascientists,
engineers,andanalyststoworktogetherondataprojects.Itintegrateswithvariousbigdatatechnologiestoofferscalabledataprocessingcapabilities.
IPOrationale
•Databricksraisedmorethan$500millionata1.12xvaluationstepupto$43.2
billioninlate2023,achievingalarge-scaleup-rounddespitemajorpublicmarketmultiplecompressionandongoingeconomicuncertainty
•Databrickshasdisclosedarevenuerunrateofaround$1.5billioninQ22023andhasbeenexpandingthroughmajoracquisitionsaswell,includinga$1.3billion
acquisitionofMosaicML,agenerativeAIstartup,and$100.0millionforArcion,anenterprisedatastartup.
•Despiteraisingmorethan$500millioninlate2023,thecompanyhasstatedthatithasnotchangeditsIPOroadmaportimeline.
•WeexpectthemarketappetiteforadataandAIbehemothtobemassive,asindicatedbythecompanyoriginallytargetinga$100.0millionroundandultimatelygrowingthatbyabout5x.
6
(pitchBooK
PitchBookAnalystNote:IPOPipeline:IdentifyingPotentialVC-backedIPOCandidatesin2024
RebeccaSpringer,Ph.D.
LeadAnalyst,Healthcare
rebecca.springer@
Vertical:HealthcareIT
Founded:2017
Founder:TravisMay
Lastraised:Undisclosed,January1,2022
Totalraised:$83.0million
Post-moneyvaluation:
$7.0billion,July28,2021
Notableinvestors:CignaVentures,Johnson&JohnsonInnovation-JJDC,MerckGlobal
HealthInnovationFund,MubadalaInvestmentCompany,NewMountainCapital,Roivant
Sciences,SixthStreetPartners
Revenue:$700.0millionfollowingCiox
mergerin2021;profitable
Publiccompetitors:
ChangeHealthcare(Optum),HealthCatalyst
Privatecompetitors:InovalonHoldings,
Clarify,Redox,Commure,Clearsense,HealthGorilla,ZusHealth
VCExitPredictor
.IPO:70%probability.M&A:16%probability.Noexit:14%probability
Note:Probabilitydataisbasedon
PitchBookVCExitPredictorMethodology.
Datavant
Companyoverview
Datavantistheleadinghealthcaredatalogisticsplatform,supporting
interoperabilityandanalysisofclinicaldataaswellasrevenuecyclefunctions.
SpunoutofRoivantSciencesin2017,thecompanybeganasareal-worlddata
(RWD)platform,helpingpharmaceuticalindustryclientsanalyzepatientdata,
includingunstructurednotes,forclinicaltrialdesignandoutcomestracking.In2021,DatavantunderwentatransformationalmergerwithCioxHealth,aclinicaldata
exchangenetwork.ThedealallowedDatavant’sRWDtechnologytoconnecttoabroadfootprintofclinicaldatasourcesandaddadditionalbusinesslines,includingrevenuecycleandcodingcapabilities.
IPOrationale
•Datavanthasthescaleanddominantmarketpositiontomakeitanobvious
IPOcandidate.Thecompanycountsmorethan70,000hospitalsandclinics,
including70%ofthe100largesthealthsystems,asitsclients.Itsdataecosystemproductsarestickyduetohighswitchingcosts.Datavant’srootsinlifesciencesandRWDarealsoadvantageousasmajorprovidersandpayerscontinueto
experiencemarginpressurepost-COVID.
•Datavant’sdiversebusinesslinescouldbeaconcernforpublicmarkets
investors.Itsrevenuecycleservices,forinstance,operateinahighlycompetitivemarketwithlowermargins.Early-stagebutwell-fundedchallengersareseekingtotakemarketshareindatainteroperability,andincumbentEHRleaderEpichascompetingproducts.
7
Vertical:Gaming
Founded:1991
Founders:TimSweeney,MarkRein
Lastraised:$1.5billion,February7,2024Totalraised:$7.6billion,April11,2022
Post-moneyvaluation:
$31.5billionDecember1,2021
Notableinvestors:FranklinTempleton,ManhattanVenturePartners,
AllianceBernstein,Tencent,Blackrock,Sony,KleinerPerkins,LightspeedVenturePartners,T.RowePrice
Revenue:$6.7billioninrevenue(2022),19.6%EBITDAmargin
Publiccompetitors:Unity,Roblox,
ElectronicArts
Privatecompetitors:
Voodoo,Niantic,RecRoom
VCExitPredictor
.IPO:94%probability.M&A:1%probability.Noexit:5%probability
Note:Probabilitydataisbasedon
PitchBookVCExitPredictorMethodology.
(pitchBooK
PitchBookAnalystNote:IPOPipeline:IdentifyingPotentialVC-backedIPOCandidatesin2024
EricBellomo
Analyst,EmergingTechnologyeric.bellomo@
EpicGames
Companyoverview
EpicGamesisaleadinginteractiveentertainmentcompanyandSaaSprovider.
Epic’shitopen-worldgameFortniteisoneofthemostpopulargamesinhistory,anditrecentlysetanewconcurrentplayerrecordwhen44.7millionusersloggedover100millionhourswiththeFortniteOGmap.2,3Thecompany’sUnrealEngineisusedacrossfilm,television,games,architecture,manufacturing,andmore.ThecompanyalsolaunchedtheEpicGamesstorein2018asagamesdistributionplatform.Acrosstheseplatforms,Epicoperatesasanend-to-enddigitalecosystemfordevelopers
andcreators.
IPOrationale
•Acrossthreedecadesasaprivatecompany,EpicGameshasraisedmorethan$6billion.Themostrecentlydisclosedvaluationwas$31.5billionin2022,althoughrecentreportingindicatesitsvaluationiscloserto$23.0billionafterastrategicinvestmentfromDisney.Thecompany’srevenuecompositionisrelatively
diversifiedwithapresenceincontent(Fornite),SaaS(UnrealEngine),distribution&publishing(EpicGamesStore),andmore.Onlytwogamingacquisitionsin
history(excludingMicrosoft’soutlierdealforActivisionBlizzard)exceedEpic’svaluation,makingapubliclistingthemostlikelyoutcome.
•TherecentsuccessofFortnite’s“BigBang”launch(whichincludedLEGOFortnite,RocketRacing,andFortniteFestival),improvementsintheUnreal
EngineforFortnitealongsidethecompany’scommitmenttocreatorecosystems,andUnrealutilizationinothercreativeindustries(suchasfilm)arepositive
indicatorsforfuturerevenuegrowth.
•EpicleadershiphasbeennoncommitalaboutIPOrumorsinthepast.OngoinglegalbattleswithApple,Google,Value,andotherscomplicatethenear-term
listingoutlook.Further,themixedperformanceofrecentgamingIPOsaddsrisktoentertainmentIPOs.
2:“FortniteJusthadItsBiggestDayEver,6Yearsin,”Polygon,OliWelsh,November6,2023.
3:“TheTremendousYetTroubledStateofGamingin2024,”MatthewBall,MatthewBall,January23,2024.
8
Note:Probabilitydataisbasedon
PitchBookVCExitPredictorMethodology.
(pitchBooK
PitchBookAnalystNote:IPOPipeline:IdentifyingPotentialVC-backedIPOCandidatesin2024
AlexFrederick
SeniorAnalyst,
EmergingTechnology
alex.frederick@
Vertical:Agtech(farm
managementsoftware)
Founded:2014
Founders:CharlesBaron,MatthewMeisner,AmolDeshpande
Lastraised:$154.9million,October13,2023
Totalraised:$939.3million
Post-moneyvaluation:
$3.8billion,November18,2021
Notableinvestors:ADMVentures,FidelityManagement,Blackrock,TemasekHoldings,T.RowePrice,GV,KleinerPerkins
Revenue:N/A
Publiccompetitors:Deveron
Privatecompetitors:Bushel,Growmark,FarmBureauFinancialServices
VCExitPredictor
.IPO:79%probability.M&A:19%probability.Noexit:2%probability
FarmersBusinessNetwork(FBN)
Companyoverview
FBNoperatesasadigitalplatformthataggregatesagriculturaldataandprovidesfarmerswithaccesstovaluableinsightsandresources.Throughitsplatform,
farmerscananalyzeagronomicdata,compareinputprices,accessmarket
intelligence,andcollaboratewithothermemberstomakeinformeddecisionsabouttheirfarmingoperations.Additionally,FBNofferscollectivepurchasingprograms
thatallowfarmerstoleveragetheircombinedpurchasingpowertonegotiatebetterpricesforseeds,chemicals,andotherinputs.
IPOrationale
•FBNhasraisedmorethan$200millionandhasestablisheditselfasaleading
playerintheagriculturaltechnologysector,offeringinnovativesolutionsand
servicestofarmers.Itsdigitalplatform,data-driveninsights,andcollective
purchasingpowerhaveresonatedwellwiththefarmingcommunity,resultinginagrowingcustomerbaseandmarketpresence.
•FBN’suserbasehasbeensteadilygrowing,andits75,000farmermemberbasedrivesstrongnetwork-effectbenefits.
•FBNcollectsextensivedataonfarmingpractices,cropyields,andmarkettrends.Thisdata-drivenapproachallowsittooffervaluableservicesandinsights.
FBNcontinuallyinnovatesbyintroducingnewtools,services,andpartnerships.Itsfocusonimprovingfarmers’profitabilityresonateswithinvestorsseekingdisruptivetechnologies.
9
Vertical:Biopharma
Founded:2018
Founders:FlagshipPioneering(VentureBuilder),MollyGibson,GevorgGrigoryan,GeoffreyvonMaltzahn,AvakKahvejian
Lastraised:$273.0million,September6,2023
Totalraised:$673.0million
Post-moneyvaluation:$2.0billion,
September6,2023
Notableinvestors:FlagshipPioneering,ARCHVenturePartners,Amgen,NVentures,T.RowePrice,FidelityManagement&Research
Revenue:N/A-Clinical,Phase1
Publiccompetitors:IsomorphicLabs,Schrödinger,Absci
Privatecompetitors:
Evolutionaryscale,Evozyne,CradleBio
VCExitPredictor
.IPO:95%probability.M&A:2%probability.Noexit:3%probability
Note:Probabilitydataisbasedon
PitchBookVCExitPredictorMethodology.
(pitchBooK
PitchBookAnalystNote:IPOPipeline:IdentifyingPotentialVC-backedIPOCandidatesin2024
KaziHelal,Ph.D.
SeniorAnalyst,Biotech
kazi.helal@
Generate:Biomedicines
Companyoverview
Generate:Biomedicinesisadeveloperofagenerativebiologyplatformdesignedtoinventnewdrugsacrossproteinmodalitiesandproteintherapeutics.Thecompany’splatformleveragesmachinelearningtounderstandthegeneticcodeunderlyingthefunctionofproteinstorapidlygenerateantibodies,peptides,enzymes,andcellandgenetherapiestomeetanytherapeuticneed,enablingbiologiststobringradicallynewmedicinestopatients.
IPOrationale
•Thecompanyisaunicornanddemonstratedcontinuedinvestorinterestwithalargepipelineofmorethan18programs,withtwodrugsinclinicaltrials.
•WhileGenerate:Biomedicinesisattheclinicalstage,inpreviousyears,AI
biotechsatthepre-clinicalstagehavegonepublicbasedontechnology
potential.GenAIrenewedtheinterestinthecomputationaldrugdesignspaceandholdsexcitementforinvestorsacrossindustries.
•Thenotablehealthcareinvestorshaveatrackrecordofpre-clinicalIPOs,
and2024isshowingpromiseforbiotechIPOs,includingoneslackingclinicalvalidation.Also,clinicaldevelopmenttimelinesarelong,soinvestorsmaywishtoexitearlier.
10
Note:Probabilitydataisbasedon
PitchBookVCExitPredictorMethodology.
(pitchBooK
PitchBookAnalystNote:IPOPipeline:IdentifyingPotentialVC-backedIPOCandidatesin2024
AlexFrederick
SeniorAnalyst,
EmergingTechnology
alex.frederick@
Vertical:Foodtech(OnlineGrocers)
Founded:2015
Founders:NazimSalur,MertSalur,Serkan
Borancili,TuncayTutek,AzizGunel,
ArkadyVolozh
Lastraised:$500.0million,
September8,2023
Totalraised:$2.3billion
Post-moneyvaluation:
$2.5billion,September8,2023
Notableinvestors:AbuDhabiGrowthFund,MubadalaInvestmentCompany,ADQ,SequoiaCapital,TigerGlobalManagement,Sofina
Revenue:$460.5millionin2022
Publiccompetitors:DeliveryHero,DoorDash,Deliveroo,UberEats,Instacart
Privatecompetitors:
Flink,GoPuff,JOKR,Zepto
VCExitPredictor
.IPO:91%probability
.M&A:7%probability.Noexit:2%probability
Getir
Companyoverview
Getirisanon-demanddeliveryservicethatspecializesinultra-fastgrocerydeliveryandconvenienceretail.Throughitsmobileapp,Getirallowscustomerstobrowseawideselectionofgroceryitems,householdessentials,andotherconvenience
productsandhavethemdeliveredtotheirdoorstepinminutes.Getir’sunique
sellingpropositionliesinitspromiseofr
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 服装设计师试用期管理指南
- 果园规划设计租赁合同
- 施工期间成本效益分析报告协议
- 会议服务投标质量保证承诺书
- 精密仪器生产仓库租赁合同
- 信息技术预算概算编制细则
- 交通运输公司物业维护手册
- 航空航天房产合同样本
- 建筑供书店人工费施工合同
- 四川省社区环境卫生规范
- 劳动教育学习通超星期末考试答案章节答案2024年
- 2024秋九年级英语上册 Module 3 Heroes Unit 3 Language in use教案(新版)外研版
- 《CSCO肿瘤相关性贫血临床实践指南(2024)》解读
- 人工肝技术护理
- 云南省2023年秋季学期期末普通高中学业水平考试信息技术(含答案解析)
- 鱼菜共生新型生态项目可行性研究报告模板-立项备案
- 中医美容课件11、足少阳胆经
- 程序员兼职合同协议模板范本(2024版)
- 意外伤害保险行业市场调研分析报告
- 智慧园区建设规范:第2部分 平台建设
- 二甲评审迎检注意事项及技巧
评论
0/150
提交评论